TransMedics Group, Inc.
TMDX
$117.38
$2.201.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 531.29M | 488.23M | 441.54M | 401.09M | 358.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 531.29M | 488.23M | 441.54M | 401.09M | 358.76M |
| Cost of Revenue | 213.62M | 197.88M | 179.46M | 163.10M | 140.95M |
| Gross Profit | 317.68M | 290.35M | 262.08M | 237.99M | 217.81M |
| SG&A Expenses | 177.27M | 176.08M | 168.62M | 154.27M | 142.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 454.72M | 435.71M | 404.04M | 367.64M | 330.35M |
| Operating Income | 76.58M | 52.52M | 37.50M | 33.46M | 28.41M |
| Income Before Tax | 74.09M | 50.06M | 35.78M | 32.65M | 1.48M |
| Income Tax Expenses | 2.43M | 1.11M | 316.00K | 16.00K | -1.52M |
| Earnings from Continuing Operations | 71.66 | 48.95 | 35.46 | 32.64 | 3.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.66M | 48.95M | 35.46M | 32.64M | 3.00M |
| EBIT | 76.58M | 52.52M | 37.50M | 33.46M | 28.41M |
| EBITDA | 100.30M | 74.11M | 57.25M | 51.14M | 42.81M |
| EPS Basic | 2.12 | 1.46 | 1.07 | 0.99 | 0.08 |
| Normalized Basic EPS | 1.37 | 0.93 | 0.68 | 0.66 | 0.58 |
| EPS Diluted | 1.94 | 1.37 | 1.02 | 0.93 | 0.03 |
| Normalized Diluted EPS | 1.17 | 0.83 | 0.64 | 0.62 | 0.55 |
| Average Basic Shares Outstanding | 134.67M | 133.87M | 132.91M | 131.97M | 131.14M |
| Average Diluted Shares Outstanding | 151.37M | 146.10M | 140.86M | 139.83M | 136.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |